Zdrowie i gospodarka · 23/03/2012
FDA Classifies Near Infrared Brain Hematoma Detector into Class II Special Controls
The FDA has classified the Near Infrared Brain Hematoma Detector into Class II special controls to ensure the device provides a reasonable assurance of safety and effectiveness.
Source: Federal Register — Food and Drug AdministrationOpen original release →